What is CaliPharms, Inc. (KGET) stock price today?

CaliPharms, Inc. (KGET) is currently trading at $0.00.

What is KGET P/E ratio?

CaliPharms, Inc.'s P/E ratio is -0.40. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is KGET return on equity (ROE)?

CaliPharms, Inc.'s return on equity (ROE) is 25.00%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is CaliPharms, Inc.'s market cap?

CaliPharms, Inc. has a market capitalization of $474349.

OTC · Drug Manufacturers - Specialty & Generic

CaliPharms, Inc. (KGET) Stock

$0.00 OTC: KGET Healthcare

CaliPharms, Inc. is an entity actively engaged in the medicinal cannabis industry across the United States.

Valuation

Metric	Value
Price	$0.00
Market Cap	$474349
P/E Ratio	-0.40
P/B Ratio	-0.11
P/S Ratio	39.53
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	25.00%
ROA	—
ROCE	34.01%
Gross Margin	100.00%
Operating Margin	—
Net Margin	—
Debt/Equity	0.00
Current Ratio	0.00

Annual Financials (USD)

Metric	2012	2013	2015	2016	2017
Revenue	—	$0	$0	$0	$0
Operating Profit	—	$0	$0	$0	$-1.0M
Net Profit	—	$0	$-1.0M	$0	$-1.0M
EPS	—	$0.00	$0.00	$0.00	$0.00
Op Margin	—	—	—	—	-11222.7%

Balance Sheet (USD)

Metric	2012	2013	2015	2016	2017
Total Assets	$0	$0	$0	$0	$0
Total Liabilities	$0	$0	$10.0M	$10.0M	$4.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$0	$0	$1.0M	$1.0M	$0

Cash Flow (USD)

Metric	2012	2013	2015	2016	2017
Operating Cash Flow	—	$0	$0	$0	$0
Investing Cash Flow	—	$0	$0	$0	$0
Financing Cash Flow	—	$0	$0	$0	$0
Net Cash Flow	—	$0	$0	$0	$0
Free Cash Flow	$0	$0	$0	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.62
FCF Yield	-34.20%
Quick Ratio	0.00
Interest Coverage	-17.57
Return 1Y	0.00%
Return 3Y	300.00%
Return 5Y	-60.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CPYCFCompliance Energy Corporation	$0.00	—	—	$7814	0.00%
GTCPGeorgetown Corporation	$0.00	—	—	$680	0.00%
MTMWMatmown, Inc.	$0.00	—	—	$9523	0.00%
NSAUFMegumaGold Corp.	$0.00	—	-0.01	$22034	0.00%
PNLTPaneltech International Holdings, Inc.	$0.00	—	-0.01	$8723	0.00%

About CaliPharms, Inc.

CaliPharms, Inc. is an entity actively engaged in the medicinal cannabis industry across the United States. The company's primary focus lies within the THC and CBD-infused beverage sector. It rebranded to CaliPharms, Inc. in January 2017, having previously operated under the name Kleangas Energy Technologies, Inc. The corporate headquarters for CaliPharms, Inc. are located in Temecula, California.

CaliPharms, Inc. (KGET) stock trades at $0.00 with a market capitalization of $474349. The stock is valued at a price-to-earnings (P/E) ratio of -0.40, price-to-book of -0.11, price-to-sales of 39.53. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, CaliPharms, Inc. generates a return on equity (ROE) of 25.00% — well above the market average, a sign of a high-quality business, return on capital employed of 34.01%.

Official website: www.calipharmsinc.com